Enbrel Schizophrenia Symptoms Reviewed by Health Canada

|

In response to concerns raised by a recent medical journal report, Canadian health officials indicate that they have conducted a safety review to evaluate the potential side effects of Enbrel and determine whether the anti-inflammation drug may increase the risk of users experiencing schizophrenia.

In a statement released late last month, Health Canada states that it could find no evidence of a link between Enbrel and schizophrenia symptoms based on available data. However, the agency will continue to monitor adverse event reports and medical literature on the issue.

Enbrel (etanercept) is a Tumor Necrosis Factor (TNF) Blocker distributed sold by Amgen which was introduced in 1998 to treat various auto immune disorders, such as Crohn’s disease, rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and juvenile idopathic arthritis (previously known as juvenile rheumatoid arthritis). It is administered as an injection.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

The safety review was sparked by a case report published last year in the medical journal The BMJ, in which doctors from the Ysbyty Gwynedd Hospital in Wales described a woman taking Enbrel who began to develop a schizophrenia-like disorder shortly after starting the treatment.

The middle-aged woman had no history of psychiatric illness and she recovered after being removed from Enbrel and after she was treated with an atypical antipsychotic, sulpiride, for six months. Sulpiride, sold under a variety of brand names worldwide, is not approved for use in the U.S.

Health Canada’s investigation found 25 reports of psychiatric disorders and two incidents of psychosis among those who took Enbrel in Canada, via reports submitted to the Canada Vigilance Program. However, the agency found no cases of schizophrenia. Warnings provided to users already indicate that Enbrel side effects may increase the risk of anxiety and depression.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries.
A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials.